Edition:
India

Parabolic Drugs Ltd (PARB.NS)

PARB.NS on National Stock Exchange of India

7.20INR
25 May 2017
Change (% chg)

Rs-0.20 (-2.70%)
Prev Close
Rs7.40
Open
Rs7.30
Day's High
Rs7.35
Day's Low
Rs6.85
Volume
22,497
Avg. Vol
68,085
52-wk High
Rs10.40
52-wk Low
Rs3.45

PARB.NS

Chart for PARB.NS

About

Parabolic Drugs Limited is a holding company. The Company is an integrated, research-based, pharmaceutical manufacturer and exporter, engaged in development and manufacturing of Active Pharmaceutical Ingredients (API) and API intermediates. It is engaged in the manufacture of pharmaceuticals, medicinal chemical and botanical... (more)
No analyst recommendations are available for PARB.NS.

Overall

Beta: 0.91
Market Cap(Mil.): Rs557.03
Shares Outstanding(Mil.): 61.89
Dividend: --
Yield (%): --

Financials

  PARB.NS Industry Sector
P/E (TTM): -- 29.41 30.38
EPS (TTM): -23.35 -- --
ROI: -22.87 13.85 13.36
ROE: -39.87 14.79 14.50

BRIEF-Parabolic Drugs appoints Ashok Kumar Jindal as CFO

* Says appointed Ashok Kumar Jindal as CFO Source text: (http://bit.ly/2q295Nq) Further company coverage:

10 May 2017

BRIEF-Parabolic Drugs Dec-qtr loss narrows

* Dec quarter net loss 454 million rupees versus loss 1.79 billion rupees year ago

09 Feb 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.